doi: 10.5698/1535-7511-11.2.54.
Brand spanking? The presumptive risks of generic antiepileptic drugs
- PMID: 21852877
- PMCID: PMC3117498
- DOI: 10.5698/1535-7511-11.2.54
Item in Clipboard
Brand spanking? The presumptive risks of generic antiepileptic drugs
Epilepsy Curr.
2011 Mar.
No abstract available
Similar articles
-
Comparative effectiveness of generic versus brand-name antiepileptic medications.Epilepsy Behav. 2015 Nov;52(Pt A):14-8. doi: 10.1016/j.yebeh.2015.08.014. Epub 2015 Sep 19. Epilepsy Behav. 2015. PMID: 26386779
-
An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.Hong Kong Med J. 2017 Feb;23(1):74-88. doi: 10.12809/hkmj166027. Hong Kong Med J. 2017. PMID: 28184017 Review.
-
Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?Epilepsia. 2018 Jul;59(7):1273-1281. doi: 10.1111/epi.14439. Epub 2018 Jun 12. Epilepsia. 2018. PMID: 29894004 Review.
-
Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).Epilepsy Res. 2017 Sep;135:71-78. doi: 10.1016/j.eplepsyres.2017.06.007. Epub 2017 Jun 13. Epilepsy Res. 2017. PMID: 28641219 Free PMC article.
-
Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature.Springerplus. 2016 Feb 25;5:182. doi: 10.1186/s40064-016-1824-2. eCollection 2016. Springerplus. 2016. PMID: 27026878 Free PMC article. Review.
Cited by
-
Brand Spanking II: Attack of the Clones (or, The Phantom Menace).Epilepsy Curr. 2016 Sep-Oct;16(5):310-311. doi: 10.5698/1535-7511-16.5.310. Epilepsy Curr. 2016. PMID: 27799857 Free PMC article. No abstract available.
-
Bias within economic evaluations - the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug.Clinicoecon Outcomes Res. 2015 Oct 6;7:497-503. doi: 10.2147/CEOR.S90386. eCollection 2015. Clinicoecon Outcomes Res. 2015. PMID: 26504402 Free PMC article.
-
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.CNS Drugs. 2012 Aug 1;26(8):707-16. doi: 10.2165/11634260-000000000-00000. CNS Drugs. 2012. PMID: 22731934 Free PMC article.
References
-
- Bialer M, Midha KK. Generic products of antiepileptic drugs: A perspective on bioequivalence and interchangeability. Epilepsia. 2010;51:941–950. - PubMed
-
- Duh MS, Andermann F, Paradis PE, Weiner J, Manjunath R, Crémieux PY. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: The case of lamotrigine. Dis Manag. 2007;10:216–225. - PubMed
-
- Duh MS, Paradis PE, Latremouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MFT, LeLorier J. The risks and costs of multiple-generic substitution of topiramate. Neurology. 2009;72:2122–2129. - PubMed
-
- Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia. 2001;42:1255–1260. - PubMed
LinkOut - more resources
Full Text Sources
